Jump to content

Data that suggests a weight loss jab may be linked to people having suicidal thoughts needs urgent clarification, experts have said.

According to a new study, figures from a World Health Organization (WHO) database suggest a bigger proportion of reports about the drug semaglutide (Wegovy) mentioned suicidal thoughts.

This is when compared to liraglutide (another weight loss drug, also known as Saxenda).

This study using the WHO database found a signal of semaglutide-associated suicidal ideation, which warrants urgent clarification

This was particularly the case among patients who also reported taking antidepressants, the study found.

The researchers of the study, published in Jama Network Open, say the findings warrant “urgent clarification”.

Read full story

Source: The Independent, 20 August 2024

0 Comments


Recommended Comments

There are no comments to display.


Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!

Register a new account

Sign in

Already have an account? Sign in here.

Sign In Now
×
  • Create New...

Important Information

We have placed cookies on your device to help make this website better. You can adjust your cookie settings, otherwise we'll assume you're okay to continue.